BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BD Biosciences (BDX) New Product Quickly and Easily Detects Intracellular and Intranuclear Proteins


5/21/2012 11:11:14 AM

May 21, 2012 -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), recently launched the BD Pharmingen™ Transcription Factor Buffer Set, a fixation and permeabilization buffer for the detection of intracellular and intranuclear proteins by flow cytometry. Transcription factors are important proteins for development and cell differentiation.

The BD Pharmingen Transcription Factor Buffer Set was designed to improve ease-of-use and minimize processing time. This increases the resolution of positively stained cells while reducing nonspecific staining and cell loss during fixation, permeabilization and staining procedures. Flow cytometric detection of many proteins known to be expressed within various intracellular compartments, especially transcription factors, is improved with this new product.

The BD Pharmingen Transcription Factor Buffer Set offers:

- Improved sensitivity for many transcription factors, including FoxP3, RORyt and T-bet

- Improved cell recoveries

- Compatibility with many cell types, cell surface staining, and tandem dyes

- High-throughput testing via volume reduction, bulk fixing, and storage

For more information on the BD Pharmigen Transcription Factor Buffer Set, please visit http://www.bdbiosciences.com/go/tfbuffer.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES